Visualizando por Autor HERCHENHORN, DANIEL
Mostrando reg. 1 a 4 de 4
Fecha de Publicación | Título | Autor(s) |
2021 | A phase 2 randomized clinical trial of abiraterone plus ADT, apalutamide, or abiraterone and apalutamide in patients with advanced prostate cancer with non-castrate testosterone levels (LACOG 0415) | MALUF, FERNANDO C.; SCHUTZ, FABIO A.; CRONEMBERGER, EDUARDO H., etc. |
2022 | -Non-metastatic, Castration-resistant Prostate Cancer: Diagnostic and Treatment Recommendations by an Expert Panel from Brazil- | JARDIM, DENIS L.; GONÇALVES E SILVA, ADRIANO; POMPEO, ALEXANDRE SAAD FERE LIMA, etc. |
2022 | Survival analysis of the randomized phase II trial to investigate androgen signaling inhibitors with or without androgen deprivation therapy (ADT) for castration-sensitive prostate cancer: LACOG 0415 | MALUF, FERNANDO C.; SOARES, ANDREY; BASTOS, DIOGO ASSED, etc. |
2019 | The LACOG-0415 phase II trial: abiraterone acetate and ADT versus apalutamide versus abiraterone acetate and apalutamide in patients with advanced prostate cancer with non-castration testosterone levels | WERUTSKY, GUSTAVO; MALUF, FERNANDO COTAIT; CRONEMBERGER, EDUARDO HENRIQUE, etc. |